We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Anna is a senior science editor at Technology Networks. She holds a first-class honours degree in biological sciences from the University of East Anglia, before joining Technology Networks she helped organize scientific conferences.
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Microphysiological systems (MPS) are two- or three-dimensional cellular platforms that are designed to recapitulate the physiology and function of the human body in vitro. These systems are also sometimes referred to as organ-on-a-chip technologies or in vitro organ constructs. MPS are helping to broaden our mechanistic understanding of disease and have numerous applications in biology and medicine. Download this infographic to:
Discover key microphysiological system components
Explore the technological advances fueling the development of these systems
Learn about advantages, challenges and applications
After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.